02 December 2020>: Clinical Research
A Retrospective Study on the Effects of Convalescent Plasma Therapy in 24 Patients Diagnosed with COVID-19 Pneumonia in February and March 2020 at 2 Centers in Wuhan, China
Shuang Huang C* , Changxin Shen B* , Chengliang Xia F , Xiaoxing Huang C , Yourong Fu A , Li Tian E*DOI: 10.12659/MSM.928755
Med Sci Monit 2020; 26:e928755
Figure 1 The dynamic changes in the laboratory results in the days following treatment with convalescent plasma transfusion (x-axis) in a 77-year-old female patient with severe COVID-19 pneumonia. (A) Changes in the lymphocyte count during 32 days following convalescent plasma transfusion; (B) Changes in the procalcitonin (PCT) levels during the 28 days following convalescent plasma transfusion; (C) Changes in the D-dimer levels during the 32 days following convalescent plasma transfusion; (D) Changes in the serum aminotransferase (ALT) levels during the 32 days following convalescent plasma transfusion; (E) Changes in the serum aspartate transaminase (AST) levels during the 32 days following convalescent plasma transfusion; (F) Changes in the creatinine levels during the 32 days following convalescent plasma transfusion; (G) Changes in the urea levels during the 32 days following convalescent plasma transfusion.